Beschreibung
Main pathways for nanoparticle transport across the blood-brain barrier are illustrated, including adsorptive-mediated endocytosis for cationic nanoparticles and receptor-mediated transcytosis for transferrin-conjugated systems.
Figure 11
DiagramSource Paper
Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology.Cite This Figure
![Figure 11: Main pathways for nanoparticle transport across the blood-brain barrier are illustrated, including adsorptive-mediated endocytosis for cationic nanoparticles and receptor-mediated transcytosis for transferrin-conjugated systems.]() > Source: Umair Shabbir et al. "Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The I." *International journal of molecular sciences*, 2020. PMID: [33375513](https://pubmed.ncbi.nlm.nih.gov/33375513/)
<figure> <img src="" alt="Main pathways for nanoparticle transport across the blood-brain barrier are illustrated, including adsorptive-mediated endocytosis for cationic nanoparticles and receptor-mediated transcytosis for transferrin-conjugated systems." /> <figcaption>Figure 11. Main pathways for nanoparticle transport across the blood-brain barrier are illustrated, including adsorptive-mediated endocytosis for cationic nanoparticles and receptor-mediated transcytosis for transferrin-conjugated systems.<br> Source: Umair Shabbir et al. "Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The I." <em>International journal of molecular sciences</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33375513/">33375513</a></figcaption> </figure>